| Resistance to systemic therapies in clear cell renal cell carcinoma: mechanisms and management strategies P Makhov, S Joshi, P Ghatalia, A Kutikov, RG Uzzo, VM Kolenko Molecular cancer therapeutics 17 (7), 1355-1364, 2018 | 370 | 2018 |
| 18F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label … AB Jani, E Schreibmann, S Goyal, R Halkar, B Hershatter, PJ Rossi, ... The Lancet 397 (10288), 1895-1904, 2021 | 127 | 2021 |
| CD8+ T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor N Prokhnevska, MA Cardenas, RM Valanparambil, E Sobierajska, ... Immunity 56 (1), 107-124. e5, 2023 | 102 | 2023 |
| Salvage radical prostatectomy for recurrent prostate cancer: morbidity and functional outcomes from a large multicenter series of open versus robotic approaches P Gontero, G Marra, P Alessio, C Filippini, M Oderda, F Munoz, E Linares, ... The Journal of Urology 202 (4), 725-731, 2019 | 76 | 2019 |
| Treatment trends and outcomes for patients with lymph node–positive cancer of the penis SS Joshi, E Handorf, D Strauss, AF Correa, A Kutikov, DYT Chen, ... JAMA oncology 4 (5), 643-649, 2018 | 61 | 2018 |
| Biochemical characterization of a regulatory cascade controlling transcription of the Pseudomonas aeruginosa type III secretion system Z Zheng, G Chen, S Joshi, ED Brutinel, TL Yahr, L Chen Journal of biological chemistry 282 (9), 6136-6142, 2007 | 50 | 2007 |
| Treatment facility volume and survival in patients with metastatic renal cell carcinoma: a registry-based analysis SS Joshi, EA Handorf, M Zibelman, ER Plimack, RG Uzzo, A Kutikov, ... European urology 74 (3), 387-393, 2018 | 45 | 2018 |
| Prediction of significant estimated glomerular filtration rate decline after renal unit removal to aid in the clinical choice between radical and partial nephrectomy in … AG McIntosh, DC Parker, BL Egleston, RG Uzzo, M Haseebuddin, ... BJU international 124 (6), 999-1005, 2019 | 35 | 2019 |
| Oncologic and functional outcomes of radical and partial nephrectomy in pT3a pathologically upstaged renal cell carcinoma: a multi-institutional analysis SH Patel, RG Uzzo, A Larcher, B Peyronnet, BR Lane, D Pruthi, M Reddy, ... Clinical Genitourinary Cancer 18 (6), e723-e729, 2020 | 34 | 2020 |
| Sarcopenia and modified Glasgow Prognostic Score predict postsurgical outcomes in localized renal cell carcinoma MI Higgins, DJ Martini, DH Patil, R Nabavizadeh, S Steele, M Williams, ... Cancer 127 (12), 1974-1983, 2021 | 32 | 2021 |
| Differences in survival associated with performance of lymph node dissection in patients with invasive penile cancer: results from the National Cancer Database AF Correa, E Handorf, SS Joshi, DM Geynisman, A Kutikov, DY Chen, ... The Journal of urology 199 (5), 1238-1244, 2018 | 30 | 2018 |
| Renal tumor anatomic complexity: clinical implications for urologists SS Joshi, RG Uzzo Urologic Clinics 44 (2), 179-187, 2017 | 30 | 2017 |
| Oncological outcomes of salvage radical prostatectomy for recurrent prostate cancer in the contemporary era: a multicenter retrospective study G Marra, RJ Karnes, G Calleris, M Oderda, P Alessio, A Palazzetti, ... Urologic Oncology: Seminars and Original Investigations 39 (5), 296. e21-296 …, 2021 | 26 | 2021 |
| Diagnostic performance and safety of positron emission tomography with 18F-rhPSMA-7.3 in patients with newly diagnosed unfavourable intermediate-to very-high-risk prostate … DS Surasi, M Eiber, T Maurer, MA Preston, BT Helfand, D Josephson, ... European urology 84 (4), 361-370, 2023 | 22 | 2023 |
| Body composition as an independent predictive and prognostic biomarker in advanced urothelial carcinoma patients treated with immune checkpoint inhibitors DJ Martini, JM Shabto, S Goyal, Y Liu, TA Olsen, ST Evans, BL Magod, ... The Oncologist 26 (12), 1017-1025, 2021 | 20 | 2021 |
| Renal hilar lesions: biological implications for complex partial nephrectomy AF Correa, H Yankey, T Li, SS Joshi, A Kutikov, DY Chen, R Viterbo, ... Urology 123, 174-180, 2019 | 20 | 2019 |
| Baseline modified Glasgow prognostic score associated with survival in metastatic urothelial carcinoma treated with immune checkpoint inhibitors JT Brown, Y Liu, JM Shabto, DJ Martini, D Ravindranathan, EE Hitron, ... The Oncologist 26 (5), 397-405, 2021 | 17 | 2021 |
| Sporadic angiomyolipomas growth kinetics while on everolimus: results of a phase II trial DM Geynisman, BT Kadow, BM Shuch, SA Boorjian, SF Matin, ... The Journal of urology 204 (3), 531-537, 2020 | 17 | 2020 |
| Robotics training program: evaluation of the satisfaction and the factors that influence success of skills training in a resident robotics curriculum SM Lucas, DA Gilley, SS Joshi, TA Gardner, CP Sundaram Journal of endourology 25 (10), 1669-1674, 2011 | 17 | 2011 |
| Salvage radiotherapy management decisions in postprostatectomy patients with recurrent prostate cancer based on 18F-fluciclovine PET/CT guidance OA Abiodun-Ojo, AB Jani, AA Akintayo, OO Akin-Akintayo, OA Odewole, ... Journal of Nuclear Medicine 62 (8), 1089-1096, 2021 | 16 | 2021 |
